COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?

The COVID-19 vaccines currently in use have undoubtedly played the most significant role in combating the SARS-CoV-2 virus and reducing disease severity and the risk of death among those affected, especially among those with pre-existing conditions, such as diabetes. The management of blood glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, Samson Mathews, Varghese, Elizabeth, Triggle, Chris R., Büsselberg, Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952286/
https://www.ncbi.nlm.nih.gov/pubmed/35335086
http://dx.doi.org/10.3390/vaccines10030454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952286/
https://www.ncbi.nlm.nih.gov/pubmed/35335086
http://dx.doi.org/10.3390/vaccines10030454

Ejemplares similares